Therefore it is possible that the profibrogenic effect of CB1, previously documented in an experimental model of doxorubicin-induced cardiomyopathy [41], may be unimpeded in the mature mice lacking GPR55 thus resulting in the development of mild cardiac fibrosis. The gene discussed is GPR55; the disease is cardiomyopathy.